A low serum level of soluble tumor necrosis factor receptor p55 predicts response to thalidomide in advanced multiple myeloma. (Q44890925)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A low serum level of soluble tumor necrosis factor receptor p55 predicts response to thalidomide in advanced multiple myeloma. |
scientific article |
Statements
A low serum level of soluble tumor necrosis factor receptor p55 predicts response to thalidomide in advanced multiple myeloma (English)
Pål Romundstad
2 references
Anne-Tove Brenne
Lene Hejna Romstad
Peter Gimsing
Gunnar Juliusson
Ingemar Turesson
Magne Borset
Anders Sundan